• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液游离轻链κ和κ指数在多发性硬化症的诊断中与寡克隆带的表现相当。

Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis.

机构信息

Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus N, Denmark.

Department of Biomedicine, Aarhus University, Aarhus C, Denmark.

出版信息

Clin Chem Lab Med. 2018 Dec 19;57(2):210-220. doi: 10.1515/cclm-2018-0400.

DOI:10.1515/cclm-2018-0400
PMID:30055097
Abstract

Background Detection of intrathecal immunoglobulin G (IgG) synthesis by gold standard oligoclonal bands (OCB) or IgG index remains an integral part of multiple sclerosis (MS) diagnostics, although both methods have weaknesses. Emerging evidence suggests that automated detection of free light chains (FLC) in the cerebrospinal fluid (CSF) has diagnostic performance equal to OCB. The objective of this study was to compare the diagnostic performance of CSF FLC with OCB and IgG index in a large cohort of Scandinavian patients referred for MS evaluation. Methods We prospectively included 230 patients suspected for MS. They are composed of patients with MS (n=96), clinically isolated syndrome (n=37), other neurological diseases (OND, n=31) and symptomatic controls (SC, n=66). CSF and serum samples were analyzed for kappa and lambda FLC, OCB and IgG index. Diagnostic performance was evaluated by receiver operating characteristic (ROC) analysis. Results Both the absolute concentration of CSF-kappa and the kappa index had excellent MS diagnostic performances with ROC area under the curve of 0.93 and 0.94 (MS vs. SC+OND). At the 0.42 mg/L cutoff, CSF-kappa had sensitivity and specificity of 93.8% and 85.6%, whereas sensitivity and specificity for OCB was 82.3% and 93.8% (72.9% and 95.9% for IgG index at cutoff 0.64). CSF-lambda and lambda index performed inferior to CSF-kappa and kappa index. Conclusions CSF-kappa and kappa index represent automated, rapid and low-cost alternatives to OCB. Using merely the absolute concentration of CSF-kappa is a logistic advantage in the clinical laboratories.

摘要

背景 金标准寡克隆带(OCB)或 IgG 指数检测鞘内 IgG 合成仍然是多发性硬化症(MS)诊断的一个组成部分,尽管这两种方法都有其弱点。新出现的证据表明,脑脊液(CSF)中游离轻链(FLC)的自动检测具有与 OCB 相等的诊断性能。本研究的目的是在一个大型的斯堪的纳维亚 MS 评估患者队列中,比较 CSF FLC 与 OCB 和 IgG 指数的诊断性能。

方法 我们前瞻性纳入了 230 名疑似 MS 的患者。他们由 MS 患者(n=96)、临床孤立综合征(n=37)、其他神经系统疾病(OND,n=31)和症状性对照(SC,n=66)组成。对 CSF 和血清样本进行了 kappa 和 lambda FLC、OCB 和 IgG 指数的分析。通过接受者操作特征(ROC)分析评估诊断性能。

结果 CSF-kappa 的绝对浓度和 kappa 指数均具有出色的 MS 诊断性能,ROC 曲线下面积分别为 0.93 和 0.94(MS 与 SC+OND)。在 0.42mg/L 截点时,CSF-kappa 的敏感性和特异性分别为 93.8%和 85.6%,而 OCB 的敏感性和特异性分别为 82.3%和 93.8%(OCB 为 72.9%和 95.9%)。CSF-lambda 和 lambda 指数的性能均低于 CSF-kappa 和 kappa 指数。

结论 CSF-kappa 和 kappa 指数是 OCB 的自动化、快速和低成本替代方法。在临床实验室中,仅使用 CSF-kappa 的绝对浓度具有逻辑优势。

相似文献

1
Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis.脑脊液游离轻链κ和κ指数在多发性硬化症的诊断中与寡克隆带的表现相当。
Clin Chem Lab Med. 2018 Dec 19;57(2):210-220. doi: 10.1515/cclm-2018-0400.
2
Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.寡克隆带阴性疑似多发性硬化症患者的脑脊液κ 和 λ 游离轻链。
Eur J Neurol. 2020 Mar;27(3):461-467. doi: 10.1111/ene.14121. Epub 2019 Dec 2.
3
CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.脑脊液游离轻链作为多发性硬化症鞘内免疫球蛋白合成的标志物:一项大样本队列中血-脑脊液屏障相关评估。
Front Immunol. 2019 Mar 29;10:641. doi: 10.3389/fimmu.2019.00641. eCollection 2019.
4
Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.游离免疫球蛋白轻链脑脊液浓度在临床孤立综合征转化为多发性硬化症中的诊断和预后价值
PLoS One. 2015 Nov 25;10(11):e0143375. doi: 10.1371/journal.pone.0143375. eCollection 2015.
5
Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis.脑脊液游离轻链。不同方法检测鞘内合成的比较。
Clin Chem Lab Med. 2019 Sep 25;57(10):1574-1586. doi: 10.1515/cclm-2018-1300.
6
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis.脑脊液游离轻链与寡克隆带在多发性硬化症中的生物标志物比较。
J Neuroimmunol. 2020 Feb 15;339:577108. doi: 10.1016/j.jneuroim.2019.577108. Epub 2019 Nov 7.
7
Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?神经炎性疾病中的游离κ轻链:是补充而非替代?
Acta Neurol Scand. 2018 Oct;138(4):352-358. doi: 10.1111/ane.12969. Epub 2018 Jun 13.
8
Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands.脑脊液中κ 游离轻链用于识别寡克隆带患者。
Eur J Neurol. 2018 Sep;25(9):1134-1139. doi: 10.1111/ene.13667. Epub 2018 May 17.
9
The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.寡克隆带在卡帕无轻链时代诊断多发性硬化症中的持续意义。
Int J Mol Sci. 2018 Nov 29;19(12):3796. doi: 10.3390/ijms19123796.
10
Determination of sensitivities and specificities of cerebrospinal fluid free light chains to diagnose multiple sclerosis- a multicentric case-control study.脑脊液游离轻链对多发性硬化症诊断的灵敏度和特异性测定——一项多中心病例对照研究。
Mult Scler Relat Disord. 2023 Jun;74:104717. doi: 10.1016/j.msard.2023.104717. Epub 2023 Apr 11.

引用本文的文献

1
Real-World Laboratory Analysis of Molecular Biomarkers in Multiple Sclerosis Centers in Central-Eastern European Countries Covering 107 Million Inhabitants.中东欧国家多发性硬化症中心分子生物标志物的真实世界实验室分析,覆盖1.07亿居民。
Int J Mol Sci. 2025 Aug 26;26(17):8274. doi: 10.3390/ijms26178274.
2
The Kappa Free Light Chains Index and Central Vein Sign: Two New Biomarkers for Multiple Sclerosis Diagnosis.游离κ轻链指数与中央静脉征:多发性硬化诊断的两种新生物标志物。
Neurol Ther. 2025 Jun;14(3):711-731. doi: 10.1007/s40120-025-00737-7. Epub 2025 Apr 6.
3
Multiple Sclerosis: From the Application of Oligoclonal Bands to Novel Potential Biomarkers.
多发性硬化症:从寡克隆带的应用到新的潜在生物标志物。
Int J Mol Sci. 2024 May 15;25(10):5412. doi: 10.3390/ijms25105412.
4
Laboratory Diagnosis of Intrathecal Synthesis of Immunoglobulins: A Review about the Contribution of OCBs and K-index.鞘内免疫球蛋白合成的实验室诊断:关于 OCB 和 K-index 贡献的综述。
Int J Mol Sci. 2024 May 9;25(10):5170. doi: 10.3390/ijms25105170.
5
Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis.脑脊液游离轻链 kappa 对多发性硬化症诊断的组间诊断准确性。
Front Immunol. 2024 Apr 30;15:1385231. doi: 10.3389/fimmu.2024.1385231. eCollection 2024.
6
Novel CSF Biomarkers Tracking Autoimmune Inflammatory and Neurodegenerative Aspects of CNS Diseases.新型脑脊液生物标志物追踪中枢神经系统疾病的自身免疫性炎症和神经退行性病变方面
Diagnostics (Basel). 2022 Dec 27;13(1):73. doi: 10.3390/diagnostics13010073.
7
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.脑脊液游离轻链 κ 对多发性硬化症的诊断价值:共识声明。
Mult Scler. 2023 Feb;29(2):182-195. doi: 10.1177/13524585221134217. Epub 2022 Dec 17.
8
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.脑脊液κ 游离轻链在多发性硬化症诊断中的应用:系统评价和荟萃分析。
Mult Scler. 2023 Feb;29(2):169-181. doi: 10.1177/13524585221134213. Epub 2022 Dec 1.
9
The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis.用κ 游离轻链诊断多发性硬化症。
Medicina (Kaunas). 2022 Oct 24;58(11):1512. doi: 10.3390/medicina58111512.
10
An Update on Diagnostic Laboratory Biomarkers for Multiple Sclerosis.多发性硬化症诊断实验室生物标志物的最新进展。
Curr Neurol Neurosci Rep. 2022 Oct;22(10):675-688. doi: 10.1007/s11910-022-01227-1. Epub 2022 Oct 21.